SAB Biotherapeutics Inc.
3.56
0.01 (0.28%)
At close: Jan 15, 2025, 3:01 PM

SAB Biotherapeutics Inc. Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for SABS stock have an median target of 9.5, with a low estimate of 6 and a high estimate of 12. The median target predicts an increase of 166.85% from the current stock price of 3.56.

Analyst Consensus: Buy
Target Low Average Median High
Price $6 $9.25 $9.5 $12
Change 68.54% 159.83% 166.85% 237.08%

AI Analyst Report

Chardan Capital has reaffirmed its Buy rating for ... Unlock content with Pro Subscription

Updated Nov 07, 2024

Rating May 24Jun 24Aug 24Sep 24Oct 24Nov 24
Strong Buy 000000
Buy 213211
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 3 2 1 1

Financial Forecast this Year

Revenue This Year
1.32M
from 2.24M
Increased by -40.9%
Revenue Next Year
800.00K
from 1.32M
Increased by -39.5%
EPS This Year
-3.68
from -7.64
Increased by 51.8%
EPS Next Year
-3.09
from -3.68
Increased by 16.0%